RUBY Post-Market Registry on the Jada® System
Completed
Conditions studied: Postpartum Hemorrhage
In brief
The RUBY Study is a multicenter, observational, post-market registry designed to collect observational data on patients treated with the Jada System in the post-market setting.
Key facts
- Study ID
- NCT04995887
- Run by
- Alydia Health
- People needed
- 809
- Starts
- 2020-10-01
- Expected to finish
- 2022-04-30
- Last updated by the study team
- 2022-08-22
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Use of the Jada System (inserted into the patient and connected to vacuum).
- NOTE: There is no Exclusion Criteria in this protocol.
Where it is running
- Loma Linda University — Loma Linda, California, United States
- ChristianaCare — Newark, Delaware, United States
- Northeast Georgia Medical Center — Gainesville, Georgia, United States
- Oshsner Baptist — New Orleans, Louisiana, United States
- Allina (Abbott Northwestern) — Minneapolis, Minnesota, United States
- Long Island Jewish Medical Center — New Hyde Park, New York, United States
- Mount Sinai — New York, New York, United States
- Nyph/Cumc — New York, New York, United States
- University Hospitals — Cleveland, Ohio, United States
- Cleveland Clinic — Cleveland, Ohio, United States
- The Ohio State University — Columbus, Ohio, United States
- Ohio Health — Gahanna, Ohio, United States
- UPMC - Magee Women's Hospital — Pittsburgh, Pennsylvania, United States
- Charleston Birth Place — Mt. Pleasant, South Carolina, United States
- University of Utah — Salt Lake City, Utah, United States
- Charleston Area Medical Center — Charleston, West Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.